August 23, 2020, Coralville, IA – Emmyon is pleased to announce that patent offices in the US, Europe, Canada, Israel and Hong Kong have issued 7 new patents for compositions and/or uses of small molecules including the natural compounds ursolic acid and tomatidine, other recently discovered natural compounds that increase muscle mass, and several recently discovered novel small molecule inhibitors of skeletal muscle atrophy and obesity. These new patents increase Emmyon’s IP portfolio to 27 granted patents in the US, Europe, Canada, Japan, China, Australia, Israel and Hong Kong, with many additional pending patent applications in major markets around the world.
Home / News / Emmyon receives 7 new patents for compositions and uses of small molecules in the US, Europe, Canada, Israel and Hong Kong